MACH-1
LIVE

Serial Number

98648791

Owner

Orlance, Inc.

Attorney

Connie Ellerbach

Filing Date

Jul 15, 2024

Add to watchlist:

No watchlists yet
View on USPTO

MACH-1 Trademark

Serial Number: 98648791

MACH-1 is a trademark filed by Orlance, Inc. on July 15, 2024. The trademark is classified under Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific), Class 44 (Medical Services). The application is currently pending registration.

Owner Contact Info

Orlance, Inc. (5 trademarks)

1124 Columbia St., Suite 300
Seattle, WA 98104

Entity Type: 03

Trademark Details

Filing Date

July 15, 2024

Registration Date

Not Registered

Published for Opposition

March 4, 2025

Goods & Services

Medical services; medical testing for treatment purposes; medical analysis services for diagnostic and treatment purposes provided by medical laboratories; medical evaluation services of autoimmune diseases, infectious diseases, respiratory diseases, mucosal diseases, multiple sclerosis, type 1 diabetes; medical treatment of autoimmune diseases, infectious diseases, respiratory diseases, mucosal diseases, multiple sclerosis, type 1 diabetes

Research and development of vaccines; research and development of medicines; medical research; scientific research; clinical research; all in the field of autoimmune diseases, infectious diseases, respiratory diseases, mucosal diseases, multiple sclerosis, type 1 diabetes, immunotherapy

Vaccines; vaccine preparations; medical preparations for the treatment of autoimmune diseases, infectious diseases, respiratory diseases, mucosal diseases, multiple sclerosis, type 1 diabetes; pharmaceutical preparations and substances for the treatment of autoimmune diseases, infectious diseases, respiratory diseases, mucosal diseases, multiple sclerosis, type 1 diabetes; chemical preparations for pharmaceutical or medical purposes, namely, for the treatment of diseases affecting mucosal tissues, the immune system, respiratory tissues; chemical preparations for pharmaceutical purposes, namely, for autoimmune diseases, infectious diseases, respiratory diseases, mucosal diseases, multiple sclerosis, type 1 diabetes; chemical preparations for medical purposes, namely, for autoimmune diseases, infectious diseases, respiratory diseases, mucosal diseases, multiple sclerosis, type 1 diabetes

Filing History

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Mar 24, 2026 EXRA
SOU EXTENSION 2 GRANTED
Mar 23, 2026 EX2G
SOU EXTENSION 2 FILED
Mar 23, 2026 EXT2
SOU TEAS EXTENSION RECEIVED
Mar 23, 2026 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Aug 14, 2025 EXRA
SOU EXTENSION 1 GRANTED
Aug 13, 2025 EX1G
SOU EXTENSION 1 FILED
Aug 13, 2025 EXT1
SOU TEAS EXTENSION RECEIVED
Aug 13, 2025 EEXT
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Apr 29, 2025 NOAM
PUBLISHED FOR OPPOSITION
Mar 4, 2025 PUBO
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Mar 4, 2025 NPUB
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Feb 26, 2025 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Feb 6, 2025 CNSA
EXAMINER'S AMENDMENT ENTERED
Feb 6, 2025 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Feb 6, 2025 GNEN
EXAMINERS AMENDMENT E-MAILED
Feb 6, 2025 GNEA
EXAMINERS AMENDMENT -WRITTEN
Feb 6, 2025 CNEA
ASSIGNED TO EXAMINER
Feb 5, 2025 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Feb 4, 2025 NWOS
NEW APPLICATION ENTERED
Jul 15, 2024 NWAP